166 related articles for article (PubMed ID: 15341491)
1. 2-Pyrazolyl-N(6)-substituted adenosine derivatives as high affinity and selective adenosine A(3) receptor agonists.
Elzein E; Palle V; Wu Y; Maa T; Zeng D; Zablocki J
J Med Chem; 2004 Sep; 47(19):4766-73. PubMed ID: 15341491
[TBL] [Abstract][Full Text] [Related]
2. Novel 1,3-disubstituted 8-(1-benzyl-1H-pyrazol-4-yl) xanthines: high affinity and selective A2B adenosine receptor antagonists.
Kalla RV; Elzein E; Perry T; Li X; Palle V; Varkhedkar V; Gimbel A; Maa T; Zeng D; Zablocki J
J Med Chem; 2006 Jun; 49(12):3682-92. PubMed ID: 16759111
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
[TBL] [Abstract][Full Text] [Related]
4. N6-Cycloalkyl-2-substituted adenosine derivatives as selective, high affinity adenosine A1 receptor agonists.
Elzein E; Kalla R; Li X; Perry T; Marquart T; Micklatcher M; Li Y; Wu Y; Zeng D; Zablocki J
Bioorg Med Chem Lett; 2007 Jan; 17(1):161-6. PubMed ID: 17045477
[TBL] [Abstract][Full Text] [Related]
5. Novel 1,3-dipropyl-8-(1-heteroarylmethyl-1H-pyrazol-4-yl)-xanthine derivatives as high affinity and selective A2B adenosine receptor antagonists.
Elzein E; Kalla R; Li X; Perry T; Parkhill E; Palle V; Varkhedkar V; Gimbel A; Zeng D; Lustig D; Leung K; Zablocki J
Bioorg Med Chem Lett; 2006 Jan; 16(2):302-6. PubMed ID: 16275090
[TBL] [Abstract][Full Text] [Related]
6. A novel partial agonist of the A(1)-adenosine receptor and evidence of receptor homogeneity in adipocytes.
Fatholahi M; Xiang Y; Wu Y; Li Y; Wu L; Dhalla AK; Belardinelli L; Shryock JC
J Pharmacol Exp Ther; 2006 May; 317(2):676-84. PubMed ID: 16410404
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of novel N6-[4-(substituted)sulfonamidophenylcarbamoyl]adenosine-5'-uronamides as A3 adenosine receptor agonists.
Baraldi PG; Fruttarolo F; Tabrizi MA; Romagnoli R; Preti D; Bovero A; Pineda de Las Infantas MJ; Moorman A; Varani K; Borea PA
J Med Chem; 2004 Oct; 47(22):5535-40. PubMed ID: 15481989
[TBL] [Abstract][Full Text] [Related]
8. N6-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (TCPA), a very selective agonist with high affinity for the human adenosine A1 receptor.
Beukers MW; Wanner MJ; Von Frijtag Drabbe Künzel JK; Klaasse EC; IJzerman AP; Koomen GJ
J Med Chem; 2003 Apr; 46(8):1492-503. PubMed ID: 12672250
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological evaluation, and molecular modeling of ribose-modified adenosine analogues as adenosine receptor agonists.
Cappellacci L; Franchetti P; Pasqualini M; Petrelli R; Vita P; Lavecchia A; Novellino E; Costa B; Martini C; Klotz KN; Grifantini M
J Med Chem; 2005 Mar; 48(5):1550-62. PubMed ID: 15743197
[TBL] [Abstract][Full Text] [Related]
10. N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
Volpini R; Dal Ben D; Lambertucci C; Taffi S; Vittori S; Klotz KN; Cristalli G
J Med Chem; 2007 Mar; 50(6):1222-30. PubMed ID: 17309246
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of new N6-substituted adenosine-5'-N-methylcarboxamides as A3 adenosine receptor agonists.
Devine SM; Gregg A; Figler H; McIntosh K; Urmaliya V; Linden J; Pouton CW; White PJ; Bottle SE; Scammells PJ
Bioorg Med Chem; 2010 May; 18(9):3078-87. PubMed ID: 20385496
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activity of new potential agonists for the human adenosine A2A receptor.
Bosch MP; Campos F; Niubó I; Rosell G; Díaz JL; Brea J; Loza MI; Guerrero A
J Med Chem; 2004 Jul; 47(16):4041-53. PubMed ID: 15267242
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of 2-alkynyl-N6-methyl-5'-N-methylcarboxamidoadenosine derivatives as potent and highly selective agonists for the human adenosine A3 receptor.
Volpini R; Buccioni M; Dal Ben D; Lambertucci C; Lammi C; Marucci G; Ramadori AT; Klotz KN; Cristalli G
J Med Chem; 2009 Dec; 52(23):7897-900. PubMed ID: 19839592
[TBL] [Abstract][Full Text] [Related]
14. [3H]HEMADO--a novel tritiated agonist selective for the human adenosine A3 receptor.
Klotz KN; Falgner N; Kachler S; Lambertucci C; Vittori S; Volpini R; Cristalli G
Eur J Pharmacol; 2007 Feb; 556(1-3):14-8. PubMed ID: 17126322
[TBL] [Abstract][Full Text] [Related]
15. Selective, high affinity A(2B) adenosine receptor antagonists: N-1 monosubstituted 8-(pyrazol-4-yl)xanthines.
Kalla RV; Elzein E; Perry T; Li X; Gimbel A; Yang M; Zeng D; Zablocki J
Bioorg Med Chem Lett; 2008 Feb; 18(4):1397-401. PubMed ID: 18226896
[TBL] [Abstract][Full Text] [Related]
16. N6,5'-Disubstituted adenosine derivatives as partial agonists for the human adenosine A3 receptor.
van Tilburg EW; von Frijtag Drabbe Künzel J; de Groote M; Vollinga RC; Lorenzen A; IJzerman AP
J Med Chem; 1999 Apr; 42(8):1393-400. PubMed ID: 10212125
[TBL] [Abstract][Full Text] [Related]
17. 1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists.
Tabrizi MA; Baraldi PG; Preti D; Romagnoli R; Saponaro G; Baraldi S; Moorman AR; Zaid AN; Varani K; Borea PA
Bioorg Med Chem; 2008 Mar; 16(5):2419-30. PubMed ID: 18077171
[TBL] [Abstract][Full Text] [Related]
18. New 2-heterocyclyl-imidazo[2,1-i]purin-5-one derivatives as potent and selective human A3 adenosine receptor antagonists.
Baraldi PG; Preti D; Zaid AN; Saponaro G; Tabrizi MA; Baraldi S; Romagnoli R; Moorman AR; Varani K; Cosconati S; Di Maro S; Marinelli L; Novellino E; Borea PA
J Med Chem; 2011 Jul; 54(14):5205-20. PubMed ID: 21675777
[TBL] [Abstract][Full Text] [Related]
19. 5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species.
Cappellacci L; Franchetti P; Vita P; Petrelli R; Lavecchia A; Costa B; Spinetti F; Martini C; Klotz KN; Grifantini M
Bioorg Med Chem; 2008 Jan; 16(1):336-53. PubMed ID: 17933541
[TBL] [Abstract][Full Text] [Related]
20. 2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.
Minetti P; Tinti MO; Carminati P; Castorina M; Di Cesare MA; Di Serio S; Gallo G; Ghirardi O; Giorgi F; Giorgi L; Piersanti G; Bartoccini F; Tarzia G
J Med Chem; 2005 Nov; 48(22):6887-96. PubMed ID: 16250647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]